149 related articles for article (PubMed ID: 15797633)
1. VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix.
Soufla G; Sifakis S; Baritaki S; Zafiropoulos A; Koumantakis E; Spandidos DA
Cancer Lett; 2005 Apr; 221(1):105-18. PubMed ID: 15797633
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection.
Baritaki S; Sifakis S; Huerta-Yepez S; Neonakis IK; Soufla G; Bonavida B; Spandidos DA
Int J Oncol; 2007 Jul; 31(1):69-79. PubMed ID: 17549406
[TBL] [Abstract][Full Text] [Related]
4. [Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance].
Liao YD; Xu H; Han Q; Lei J; Zhang YY; Wang ZH
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):360-4. PubMed ID: 17892132
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis.
Van Trappen PO; Steele D; Lowe DG; Baithun S; Beasley N; Thiele W; Weich H; Krishnan J; Shepherd JH; Pepper MS; Jackson DG; Sleeman JP; Jacobs IJ
J Pathol; 2003 Dec; 201(4):544-54. PubMed ID: 14648657
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional inactivation of p53, Bax, Bcl-2 and Mdm2 correlates with malignant transformation of the uterine cervix.
Soufla G; Baritaki S; Sifakis S; Zafiropoulos A; Spandidos DA
Int J Biol Markers; 2005; 20(1):18-27. PubMed ID: 15832769
[TBL] [Abstract][Full Text] [Related]
7. A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer.
Van Trappen PO; Ryan A; Carroll M; Lecoeur C; Goff L; Gyselman VG; Young BD; Lowe DG; Pepper MS; Shepherd JH; Jacobs IJ
Br J Cancer; 2002 Aug; 87(5):537-44. PubMed ID: 12189553
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between transcriptional activity of vascular endothelial growth factor (VEFG) and transcriptional activity of its receptors (FLT-1 and FLK-1) in low-grade squamous intraepithelial lesions (LSIL) of uterine cervix].
Michalski B; Zieliński T; Fila A; Mazurek U; Poreba R; Wilczok T
Ginekol Pol; 2003 Sep; 74(9):805-10. PubMed ID: 14674128
[TBL] [Abstract][Full Text] [Related]
9. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.
Soulitzis N; Karyotis I; Delakas D; Spandidos DA
Int J Oncol; 2006 Aug; 29(2):305-14. PubMed ID: 16820871
[TBL] [Abstract][Full Text] [Related]
11. Decreased synthesis and expression of TGF-beta1, beta2, and beta3 in epithelium of HPV 16-positive cervical precancer: a study by microdissection, quantitative RT-PCR, and immunocytochemistry.
El-Sherif AM; Seth R; Tighe PJ; Jenkins D
J Pathol; 2000 Dec; 192(4):494-501. PubMed ID: 11113867
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of granzyme B and vascular endothelial growth factor (VEGF) in normal uterine cervices and low and high grade squamous intraepithelial lesions.
Belfort-Mattos PN; Focchi GR; Speck NM; Taha NS; Carvalho CR; Ribalta JC
Eur J Gynaecol Oncol; 2010; 31(4):459-61. PubMed ID: 20882896
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
Masi L; Malentacchi C; Campanacci D; Franchi A
Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta1, FGF-2, and receptor mRNA expression in suture mesenchyme and dura versus underlying brain in fusing and nonfusing mouse cranial sutures.
Gosain AK; Recinos RF; Agresti M; Khanna AK
Plast Reconstr Surg; 2004 May; 113(6):1675-84. PubMed ID: 15114129
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factors beta1, beta2 and beta3 and their receptors are differentially expressed in human peritoneal fibroblasts in response to hypoxia.
Saed GM; Collins KL; Diamond MP
Am J Reprod Immunol; 2002 Dec; 48(6):387-93. PubMed ID: 12607775
[TBL] [Abstract][Full Text] [Related]
16. Expressions of IGFBP-5, cFLIP in cervical intraepithelial neoplasia, cervical carcinoma and their clinical significances: a molecular pathology.
Hou XJ; Zhang YZ; Liu X; Meng LH; Qiao YB
J Exp Clin Cancer Res; 2009 May; 28(1):70. PubMed ID: 19476635
[TBL] [Abstract][Full Text] [Related]
17. The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma.
Dai Y; Zhang X; Peng Y; Wang Z
Gynecol Oncol; 2005 Apr; 97(1):96-103. PubMed ID: 15790444
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids recruit Tgfbr3 and Smad1 to shift transforming growth factor-β signaling from the Tgfbr1/Smad2/3 axis to the Acvrl1/Smad1 axis in lung fibroblasts.
Schwartze JT; Becker S; Sakkas E; Wujak ŁA; Niess G; Usemann J; Reichenberger F; Herold S; Vadász I; Mayer K; Seeger W; Morty RE
J Biol Chem; 2014 Feb; 289(6):3262-75. PubMed ID: 24347165
[TBL] [Abstract][Full Text] [Related]
19. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease.
Hammes LS; Tekmal RR; Naud P; Edelweiss MI; Kirma N; Valente PT; Syrjänen KJ; Cunha-Filho JS
Gynecol Oncol; 2008 Sep; 110(3):445-51. PubMed ID: 18565574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
